Skip to main content

Table 2 Logistic regression analysis showing associations between TB treatment outcomes and potential predictors, DTGH, 2008–2016

From: Treatment outcomes of tuberculosis patients under directly observed treatment short-course at Debre Tabor General Hospital, northwest Ethiopia: nine-years retrospective study

Variables TB treatment outcomea cOR (95% CI) P value aOR (95% CI) P value
Unsuccessful n (%) Successful n (%)
Sex Male 45 (5.7) 344 (94.3) 1   1  
Female 29 (8.1) 328 (91.9) 1.5(0.92.4) 0.12 1.5(0.9–2.5) 0.10
Age group (in years) 0–14 8 (11.6) 61(88.4) 1   1  
15–24 17 (7.2) 220(92.) 1.7(0.7–4) 0.24 1.8(0.73–4.46) 0.20
25–34 11 (6.4) 160(93.) 1.9(0.7–5) 0.19 2(0.77–5.4) 0.15
35–44 18 (16.5) 91 (83.5) 0.66(0.27–1.6) 0.37 0.73(0.29–1.8) 0.50
45–54 7 (9.2) 60 (90.8) 1.12(0.38–3.3) 0.8 1.18(0.4–3.5) 0.76
55–64 6 (8.3) 36 (91.7) 0.78(0.25–2.45) 0.68 0.8(0.25–2.5) 0.70
≥ 65 7 (13.7) 44 (86.3) 0.8(0.28–2.4) 0.72 0.86(0.3–2.6) 0.78
Type of TB PTB+ 18 (9.5) 171(90.5) 1   1  
PTB- 29 (10.5) 247(89.5) 0.89(0.48–1.66) 0.70 1.04(0.5–2) 0.89
EPTB 27 (9.6) 254(90.4) 0.99(0.5–1.8) 0.98 1.04(0.5–2) 0.89
TB registration status New 62 (10.1) 550(89.9) 1   1  
Relapse 4 (8.2) 45 (91.8) 1.3(0.44–3.6) 0.66 1.48(0.5–4.4) 0.47
Treatment after Failure 1(5.9) 16 (94.1) 1.8(0.23–31.8) 0.57 1.6(0.2–12.7) 0.65
Transfer in 6 (9.7) 56 (90.3) 1.05(0.44–2.5) 0.9 0.93(0.37–3) 0.87
Other 1 (16.7) 5 (83.3) 0.56(0.06–4.9) 0.6 0.37(0.04–3.3) 0.37
HIV status Positive 21 (11.9) 155(88.1) 1   1  
Negative 50 (9.2) 494(90.8) 1.33(0.78–2.3) 0.30 1.37(0.76–2.4) 0.23
Unknon 3 (11.5) 23 (88.5) 1.03(0.28–3.76) 0.95 1.13(0.3–4.2) 0.5
  1. aNB: the calculation excluded transferred out (n = 219) and treatment outcome unknown (20) cases